The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes
- PMID: 19007206
- DOI: 10.1021/ic801361m
The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes
Abstract
The synthesis and characterization of ruthenium(II) arene complexes [(eta(6)-arene)Ru(N,N)Cl](0/+), where N,N = 2,2'-bipyridine (bipy), 2,2'-bipyridine-3,3'-diol (bipy(OH)(2)) or deprotonated 2,2'-bipyridine-3,3'-diol (bipy(OH)O) as N,N-chelating ligand, arene = benzene (bz), indan (ind), biphenyl (bip), p-terphenyl (p-terp), tetrahydronaphthalene (thn), tetrahydroanthracene (tha) or dihydroanthracene (dha), are reported, including the X-ray crystal structures of [(eta(6)-tha)Ru(bipy)Cl][PF(6)] (1), [(eta(6)-tha)Ru(bipy(OH)O)Cl] (2) and [(eta(6)-ind)Ru(bipy(OH)(2))Cl][PF(6)] (8). Complexes 1 and 2 exibit CH (arene)/pi (bipy or bipy(OH)O) interactions. In the X-ray structure of protonated complex 8, the pyridine rings are twisted (by 17.31 degrees). In aqueous solution (pH = 2-10), only deprotonated (bipy(OH)O) forms are present. Hydrolysis of the complexes was relatively fast in aqueous solution (t(1/2) = 4-15 min, 310 K). When the arene is biphenyl, initial aquation of the complexes is followed by partial arene loss. Complexes with arene = tha, thn, dha, ind and p-terp, and deprotonated bipyridinediol (bipy(OH)O) as chelating ligands, exhibited significant cytotoxicity toward A2780 human ovarian and A549 human lung cancer cells. Complexes [(eta(6)-bip)Ru(bipy(OH)O)Cl] (7) and [(eta(6)-bz)Ru(bipy(OH)O)Cl] (5) exhibited moderate cytotoxicity toward A2780 cells, but were inactive toward A549 cells. These activity data can be contrasted with those of the parent bipyridine complex [(eta(6)-tha)Ru(bipy)Cl][PF(6)] (1) which is inactive toward both A2780 ovarian and A549 lung cell lines. DFT calculations suggested that hydroxylation and methylation of the bipy ligand have little effect on the charge on Ru. The active complex [(eta(6)-tha)Ru(bipy(OH)O)Cl] (2) binds strongly to 9-ethyl-guanine (9-EtG). The X-ray crystal structure of the adduct [(eta(6)-tha)Ru(bipy(OH)O)(9-EtG-N7)][PF(6)] shows intramolecular CH (arene)/pi (bipy(OH)O) interactions and DFT calculations suggested that these are more stable than arene/9-EtG pi-pi interactions. However [(eta(6)-ind)Ru(bipy(OH)(2))Cl][PF(6)] (8) and [(eta(6)-ind)Ru(bipy)Cl][PF(6)] (16) bind only weakly to DNA. DNA may therefore not be the major target for complexes studied here.
Similar articles
-
Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.Inorg Chem. 2009 Oct 5;48(19):9444-53. doi: 10.1021/ic9013366. Inorg Chem. 2009. PMID: 19780621
-
Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.Inorg Chem. 2006 Dec 25;45(26):10882-94. doi: 10.1021/ic061460h. Inorg Chem. 2006. PMID: 17173447
-
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.J Am Chem Soc. 2006 Feb 8;128(5):1739-48. doi: 10.1021/ja055886r. J Am Chem Soc. 2006. PMID: 16448150
-
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes.Chem Commun (Camb). 2005 Oct 14;(38):4764-76. doi: 10.1039/b508531b. Epub 2005 Aug 26. Chem Commun (Camb). 2005. PMID: 16193110 Review.
-
Recent developments in ruthenium anticancer drugs.Metallomics. 2009 Nov;1(6):458-70. doi: 10.1039/b904071d. Epub 2009 Aug 13. Metallomics. 2009. PMID: 21305154 Review.
Cited by
-
Pyridine-Quinoline and Biquinoline-Based Ruthenium p-Cymene Complexes as Efficient Catalysts for Transfer Hydrogenation Studies: Synthesis and Structural Characterization.Molecules. 2025 Jul 11;30(14):2945. doi: 10.3390/molecules30142945. Molecules. 2025. PMID: 40733211 Free PMC article.
-
A binuclear iron(III) complex of 5,5'-dimethyl-2,2'-bipyridine as cytotoxic agent.Biometals. 2020 Dec;33(6):365-378. doi: 10.1007/s10534-020-00255-z. Epub 2020 Oct 8. Biometals. 2020. PMID: 33033992
-
Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(p-Cymene)Cl2L] and Their Cytotoxicity against HeLa-Type Cancer Cells.Molecules. 2022 Oct 26;27(21):7264. doi: 10.3390/molecules27217264. Molecules. 2022. PMID: 36364091 Free PMC article.
-
Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.J Inorg Biochem. 2011 Aug;105(8):1019-29. doi: 10.1016/j.jinorgbio.2011.04.008. J Inorg Biochem. 2011. PMID: 21666776 Free PMC article.
-
p-Cymene Complexes of Ruthenium(II) as Antitumor Agents.Molecules. 2020 Oct 31;25(21):5063. doi: 10.3390/molecules25215063. Molecules. 2020. PMID: 33142775 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous